Clinical Trial Update: Liver MRI With Primovist/Eovist in Pediatric Subjects Who Are Suspected or Have Focal Liver Lesions.

View source ↗

Summary

This trial reported results on using Primovist/Eovist contrast-enhanced MRI to evaluate suspected or focal liver lesions in pediatric patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Adenoma
• Hepatocellular Carcinoma
• Liver Abscess
• Liver Neoplasms

Drugs mentioned

• EOVIST (GADOXETATE DISODIUM)
• Primovist (Gadoxetate disodium)

Snippet

Sponsor: Bayer | Conditions: Liver Neoplasms, Adenoma | Status: COMPLETED | Results posted: 2014-06-03